235 related articles for article (PubMed ID: 36869852)
1. TGF-β-induced PI3K/AKT/mTOR pathway controls myofibroblast differentiation and secretory phenotype of valvular interstitial cells through the modulation of cellular senescence in a naturally occurring in vitro canine model of myxomatous mitral valve disease.
Tang Q; Markby GR; MacNair AJ; Tang K; Tkacz M; Parys M; Phadwal K; MacRae VE; Corcoran BM
Cell Prolif; 2023 Jun; 56(6):e13435. PubMed ID: 36869852
[TBL] [Abstract][Full Text] [Related]
2. TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease.
McNair AJ; Markby GR; Tang Q; MacRae VE; Corcoran BM
Front Vet Sci; 2023; 10():1202001. PubMed ID: 37908840
[TBL] [Abstract][Full Text] [Related]
3. Role of PI3K/Akt/mTOR pathway-mediated macrophage autophagy in affecting the phenotype transformation of lung fibroblasts induced by silica dust exposure.
DU Y; Huang F; Guan L; Zeng M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 48(8):1152-1162. PubMed ID: 37875355
[TBL] [Abstract][Full Text] [Related]
4. Metformin alleviates the calcification of aortic valve interstitial cells through activating the PI3K/AKT pathway in an AMPK dependent way.
En Q; Zeping H; Yuetang W; Xu W; Wei W
Mol Med; 2021 Dec; 27(1):156. PubMed ID: 34895136
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-β1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model.
Jenke A; Kistner J; Saradar S; Chekhoeva A; Yazdanyar M; Bergmann AK; Rötepohl MV; Lichtenberg A; Akhyari P
Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1123-H1141. PubMed ID: 32986963
[TBL] [Abstract][Full Text] [Related]
6. Survival of activated myofibroblasts in canine myxomatous mitral valve disease and the role of apoptosis.
Blake RR; Markby GR; Culshaw GJ; Martinez-Pereira Y; Lu CC; Corcoran BM
Res Vet Sci; 2020 Feb; 128():99-106. PubMed ID: 31765842
[TBL] [Abstract][Full Text] [Related]
7. CC chemokine receptor 2 functions in osteoblastic transformation of valvular interstitial cells.
Zhu E; Liu Z; He W; Deng B; Shu X; He Z; Wu X; Ke X; Nie R
Life Sci; 2019 Jul; 228():72-84. PubMed ID: 31034839
[TBL] [Abstract][Full Text] [Related]
8. Notch1 Mutation Leads to Valvular Calcification Through Enhanced Myofibroblast Mechanotransduction.
Chen J; Ryzhova LM; Sewell-Loftin MK; Brown CB; Huppert SS; Baldwin HS; Merryman WD
Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1597-605. PubMed ID: 26023079
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis and abundance of Bcl-2 family and transforming growth factor β1 signaling proteins in canine myxomatous mitral valves.
Surachetpong S; Jiranantasak T; Rungsipipat A; Orton EC
J Vet Cardiol; 2013 Sep; 15(3):171-80. PubMed ID: 23816827
[TBL] [Abstract][Full Text] [Related]
10. The PI3K-Akt-mTOR pathway mediates renal pericyte-myofibroblast transition by enhancing glycolysis through HKII.
Chen L; Li X; Deng Y; Chen J; Huang M; Zhu F; Gao Z; Wu L; Hong Q; Feng Z; Cai G; Sun X; Bai X; Chen X
J Transl Med; 2023 May; 21(1):323. PubMed ID: 37179292
[TBL] [Abstract][Full Text] [Related]
11. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway.
Wu XL; Wang LK; Yang DD; Qu M; Yang YJ; Guo F; Han L; Xue J
J Cell Biochem; 2018 Feb; 119(2):2356-2367. PubMed ID: 28884839
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of canine 2D cell cultures as models of myxomatous mitral valve degeneration.
Tan K; Markby G; Muirhead R; Blake R; Bergeron L; Fici G; Summers K; Macrae V; Corcoran B
PLoS One; 2019; 14(8):e0221126. PubMed ID: 31415646
[TBL] [Abstract][Full Text] [Related]
13. TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves.
Hagler MA; Hadley TM; Zhang H; Mehra K; Roos CM; Schaff HV; Suri RM; Miller JD
Cardiovasc Res; 2013 Jul; 99(1):175-84. PubMed ID: 23554457
[TBL] [Abstract][Full Text] [Related]
14. Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.
Oyama MA; Elliott C; Loughran KA; Kossar AP; Castillero E; Levy RJ; Ferrari G
Cardiovasc Pathol; 2020; 46():107196. PubMed ID: 32006823
[TBL] [Abstract][Full Text] [Related]
15. Isoliquiritigenin inhibits TGF-β1-induced fibrogenesis through activating autophagy via PI3K/AKT/mTOR pathway in MRC-5 cells.
He J; Peng H; Wang M; Liu Y; Guo X; Wang B; Dai L; Cheng X; Meng Z; Yuan L; Cai F; Tang Y
Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):810-820. PubMed ID: 32638014
[TBL] [Abstract][Full Text] [Related]
16. Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K/Akt/mTOR and hedgehog signalling via increasing miR-193a expression.
Liu MW; Su MX; Tang DY; Hao L; Xun XH; Huang YQ
BMC Pulm Med; 2019 Feb; 19(1):35. PubMed ID: 30744607
[TBL] [Abstract][Full Text] [Related]
17. 5-HT(2B) antagonism arrests non-canonical TGF-β1-induced valvular myofibroblast differentiation.
Hutcheson JD; Ryzhova LM; Setola V; Merryman WD
J Mol Cell Cardiol; 2012 Nov; 53(5):707-14. PubMed ID: 22940605
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of mTORC1 but not mTORC2 protects against human disc cellular apoptosis, senescence, and extracellular matrix catabolism through Akt and autophagy induction.
Kakiuchi Y; Yurube T; Kakutani K; Takada T; Ito M; Takeoka Y; Kanda Y; Miyazaki S; Kuroda R; Nishida K
Osteoarthritis Cartilage; 2019 Jun; 27(6):965-976. PubMed ID: 30716534
[TBL] [Abstract][Full Text] [Related]
19. Klotho suppresses high phosphate-induced osteogenic responses in human aortic valve interstitial cells through inhibition of Sox9.
Li F; Yao Q; Ao L; Cleveland JC; Dong N; Fullerton DA; Meng X
J Mol Med (Berl); 2017 Jul; 95(7):739-751. PubMed ID: 28332126
[TBL] [Abstract][Full Text] [Related]
20. Nonbiased Molecular Screening Identifies Novel Molecular Regulators of Fibrogenic and Proliferative Signaling in Myxomatous Mitral Valve Disease.
Thalji NM; Hagler MA; Zhang H; Casaclang-Verzosa G; Nair AA; Suri RM; Miller JD
Circ Cardiovasc Genet; 2015 Jun; 8(3):516-28. PubMed ID: 25814644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
